Legal & General Group PLC Lyra Therapeutics, Inc. Transaction History

Legal & General Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$6.91 - $12.59 $5,244 - $9,555	-759 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$9.28 - $13.88 $3,377 - $5,052	364 Added 92.15%	759 $9,000
Q3 2020 Nov 13, 2020	SELL	$10.61 - $13.96 $2,769 - $3,643	-261 Reduced 39.79%	395 $4,000
Q2 2020 Aug 14, 2020	BUY	$10.91 - $18.56 $7,156 - $12,175	656 New	656 $7,000

32.2M

21.1K

400

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $6.68M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.